Mersana Therapeutics
MRSN
MRSN
56 hedge funds and large institutions have $295M invested in Mersana Therapeutics in 2018 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.26% more ownership
Funds ownership: 3.03% → 3.29% (+0.26%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
56
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$8.39M | |
| 2 | +$4.39M | |
| 3 | +$3.8M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.79M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.68M |
Top Sellers
| 1 | -$4.86M | |
| 2 | -$952K | |
| 3 | -$423K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$402K |
| 5 |
RCP
Rho Capital Partners
New York
|
-$340K |